Bedel Financial Consulting’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bedel Financial Consulting’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-25	Closed	-$1K	–	1007
2021 Q4	$1K	Hold	25	–	–	﹤0.01%	948
2021 Q3	$1K	Hold	25	–	–	﹤0.01%	933
2021 Q2	$2K	Hold	25	–	–	﹤0.01%	881
2021 Q1	$2K	Hold	25	–	–	﹤0.01%	849
2020 Q4	$2K	Hold	25	–	–	﹤0.01%	750
2020 Q3	$4K	Hold	25	–	–	﹤0.01%	639
2020 Q2	$5K	Hold	25	–	–	﹤0.01%	580
2020 Q1	$5K	Hold	25	–	–	﹤0.01%	568
2019 Q4	$5K	Hold	25	–	–	﹤0.01%	585
2019 Q3	$4K	Hold	25	–	–	﹤0.01%	589
2019 Q2	$3K	Hold	25	–	–	﹤0.01%	610
2019 Q1	$3K	Hold	25	–	–	﹤0.01%	608
2018 Q4	$2K	Hold	25	–	–	﹤0.01%	606
2018 Q3	$2K	Hold	25	–	–	﹤0.01%	611
2018 Q2	$2K	Hold	25	–	–	﹤0.01%	614
2018 Q1	$2K	Buy	+25	New	+$2.69K	﹤0.01%	606

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bedel Financial Consulting's LKFT Position: Q1 2022 in Review

Bedel Financial Consulting sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2022, closing a stake of 25 shares — an estimated $1K sold.

Bedel Financial Consulting first reported a position in LKFT in Q1 2018 and held it in 16 quarters. The position peaked at $5K in Q2 2020. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2022.

Bedel Financial Consulting reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Bedel Financial Consulting sold 25 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2022, an estimated $1K.
Bedel Financial Consulting first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2018 and held it in 16 quarters.
Bedel Financial Consulting's Lakefront Biotherapeutics American Depositary Shares position peaked at $5K in Q2 2020.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2022.

Based on Bedel Financial Consulting's 13F filing for Q1 2022, filed 19 Apr 2022.